PRINCIPAL FINANCIAL GROUP INC - IOVANCE BIOTHERAPEUTICS INC ownership

IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 256 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.42 and the average weighting 0.2%.

Quarter-by-quarter ownership
PRINCIPAL FINANCIAL GROUP INC ownership history of IOVANCE BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2023$12,026,346
-8.7%
2,643,155
+41.3%
0.01%0.0%
Q2 2023$13,166,562
+12.7%
1,870,250
-2.2%
0.01%
+12.5%
Q1 2023$11,687,037
+77.3%
1,912,772
+85.4%
0.01%
+60.0%
Q4 2022$6,591,867
-35.5%
1,031,591
-3.4%
0.01%
-37.5%
Q3 2022$10,226,000
+1.0%
1,067,432
+16.4%
0.01%
+14.3%
Q2 2022$10,120,000
+7.3%
916,683
+61.8%
0.01%
+16.7%
Q1 2022$9,435,000
-12.0%
566,658
+0.9%
0.01%0.0%
Q4 2021$10,721,000
-20.5%
561,587
+2.7%
0.01%
-33.3%
Q3 2021$13,486,000
-1.3%
546,867
+4.1%
0.01%0.0%
Q2 2021$13,663,000
+3.0%
525,083
+25.4%
0.01%0.0%
Q1 2021$13,261,000
-25.1%
418,872
+9.8%
0.01%
-30.8%
Q4 2020$17,699,000
+45.0%
381,453
+2.9%
0.01%
+30.0%
Q3 2020$12,202,000
+20.2%
370,674
+0.2%
0.01%
+11.1%
Q2 2020$10,152,000
+77.5%
369,868
+93.5%
0.01%
+50.0%
Q1 2020$5,721,000
+102.2%
191,108
+86.9%
0.01%
+200.0%
Q4 2019$2,830,000
+324.9%
102,250
+179.3%
0.00%
+100.0%
Q3 2019$666,000
-18.5%
36,615
+9.9%
0.00%0.0%
Q2 2019$817,000
+193.9%
33,312
+14.0%
0.00%
Q1 2019$278,000
+26.4%
29,217
+17.4%
0.00%
Q4 2018$220,000
-33.1%
24,897
-14.8%
0.00%
Q3 2018$329,000
+2.2%
29,234
+16.3%
0.00%
Q2 2018$322,00025,1260.00%
Other shareholders
IOVANCE BIOTHERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
ACUTA CAPITAL PARTNERS, LLC 2,944,201$27,999,00013.31%
Broadfin Capital, LLC 4,328,303$41,162,0008.50%
GREAT POINT PARTNERS LLC 5,567,348$52,945,0005.24%
FRAZIER MANAGEMENT LLC 2,188,331$20,811,0005.01%
Avoro Capital Advisors LLC 10,530,862$100,148,0004.33%
Prosight Management, LP 917,080$8,721,0003.82%
Perceptive Advisors 12,235,811$116,362,0003.28%
Ghost Tree Capital, LLC 1,150,000$10,937,0002.86%
QVT Financial LP 1,021,361$9,241,0002.32%
Cheyne Capital Management (UK) LLP 186,500$1,774,0001.66%
View complete list of IOVANCE BIOTHERAPEUTICS INC shareholders